Clinical Trials on Lymphoma in Hong Kong
Total 179 results
-
TakedaSeagen Inc.Active, not recruitingHodgkin LymphomaUnited States, France, Italy, Poland, United Kingdom, Belgium, Hong Kong, Taiwan, Spain, South Africa, Turkey, Canada, Denmark, Korea, Republic of, Australia, Russian Federation, Brazil, Hungary, Norway, Czechia, Japan
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage I Childhood Hodgkin Lymphoma | Ann Arbor Stage II Childhood Hodgkin Lymphoma | Childhood Nodular Lymphocyte Predominant B-Cell LymphomaUnited States, Canada, Australia, New Zealand, Puerto Rico, Israel
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedStage III Childhood Hodgkin Lymphoma | Stage IV Childhood Hodgkin Lymphoma | Childhood Nodular Lymphocyte Predominant Hodgkin LymphomaUnited States, Canada, Israel, Australia, Puerto Rico
-
National Cancer Institute (NCI)RecruitingPrimary Mediastinal Large B-Cell LymphomaUnited States, Canada, Australia, Puerto Rico
-
Incyte CorporationChildren's Oncology GroupActive, not recruitingLeukemiaUnited States, Canada, Puerto Rico
-
Chiron CorporationCompletedLymphoma, Non-HodgkinUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | Acute Undifferentiated Leukemia | Childhood T Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, New Zealand
-
National Cancer Institute (NCI)RecruitingLugano Classification Limited Stage Hodgkin Lymphoma AJCC v8United States, Puerto Rico, Canada
-
National Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Canada
-
PfizerCompletedFollicular LymphomaUnited States, Spain, United Kingdom, Korea, Republic of, France, Portugal, India, Mexico, Switzerland, Japan, Germany, Romania, Greece, Austria, Belgium, Italy, Thailand, Croatia, Philippines, Russian Federation, Puerto Rico, Ukr... and more
-
GenmabAbbVieRecruitingFollicular Lymphoma (FL)Austria, Greece, Israel, Korea, Republic of, Spain, Hungary, Sweden, Switzerland, France, Poland, Taiwan, Australia, Denmark, New Zealand, Turkey, Italy, Netherlands, Belgium, Canada, South Africa, Czechia, Brazil, Germany, Argentina, United... and more
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Childhood Acute Lymphoblastic LeukemiaUnited States, Australia, Canada, Puerto Rico
-
GenmabAbbVieRecruitingDiffuse Large B-Cell LymphomaKorea, Republic of, Spain, Japan, Israel, Australia, Poland, Netherlands, Sweden, Greece, Taiwan, Italy, Denmark, Switzerland, France, Bulgaria, Hungary, Austria, New Zealand, Czechia, Croatia, Belgium, Brazil, China, United States, Canada and more
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
BayerTerminatedLymphoma, Non-HodgkinUnited States, Hungary, China, Belgium, Korea, Republic of, France, Australia, Russian Federation, Taiwan, Denmark, Japan, United Kingdom, Spain, South Africa, Turkey, Romania, Singapore, Israel, Ireland, Canada, Poland, Greece, Cze... and more
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingLymphoma, Mantle-CellUnited States, China, Spain, Belgium, Canada, Australia, Czechia, Italy, Taiwan, Germany, Japan, New Zealand, United Kingdom, Denmark, Brazil, Israel, France, Netherlands, Korea, Republic of, Poland, Hungary, Austria, Switzerland, Por... and more
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedAcute Lymphoblastic LeukemiaUnited States, Canada, Puerto Rico, Australia, New Zealand, Switzerland, Ireland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemia | Neurotoxicity | Long-term Effects Secondary to Cancer Therapy in Children | Psychosocial Effects of Cancer and Its TreatmentUnited States
-
Bristol-Myers SquibbChildren's Oncology Group; EsPhALLCompletedLeukemia, PediatricUnited States, Canada, United Kingdom, Italy, Australia, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Australia, Switzerland, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States, Australia, Canada
-
National Cancer Institute (NCI)SuspendedRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin LymphomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Childhood B Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, New Zealand, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Lymphoblastic Leukemia in RemissionUnited States, Canada, Australia
-
Taiho Oncology, Inc.Active, not recruitingAdvanced or Metastatic Solid Tumor | Advanced or Metastatic Gastric or Gastroesophageal Cancer | Myeloid or Lymphoid Neoplasms (MLN)United States, Spain, Turkey, Hong Kong, Korea, Republic of, Belgium, Japan, Netherlands, France, Germany, Italy, Sweden, United Kingdom, Portugal, Singapore
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States, Canada, Puerto Rico, Australia, Netherlands, New Zealand, Switzerland
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Refractory Neuroblastoma | Refractory Non-Hodgkin Lymphoma | Refractory Primary Central Nervous System Neoplasm | Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma and other conditionsUnited States, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States, Canada, Australia
-
Merck Sharp & Dohme LLCActive, not recruitingHodgkin LymphomaUnited States, Brazil, Colombia, Czechia, France, Germany, Greece, Guatemala, Italy, Korea, Republic of, Mexico, Netherlands, Slovakia, South Africa, Spain, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingRecurrent B Acute Lymphoblastic LeukemiaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia | Childhood B Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, New Zealand, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedUntreated Adult Acute Lymphoblastic Leukemia | Untreated Childhood Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, New Zealand, Puerto Rico, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Puerto Rico, Australia, Netherlands, New Zealand, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States, Australia, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedUntreated Childhood Acute Lymphoblastic Leukemia | Childhood T Acute Lymphoblastic Leukemia | Neurotoxicity Syndrome | Childhood B Acute Lymphoblastic Leukemia | Cognitive Side Effects of Cancer Therapy | Psychological Impact of Cancer | Long-Term Effects Secondary to Cancer Therapy in ChildrenUnited States, Canada, Australia, New Zealand
-
National Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Israel
-
National Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingB Acute Lymphoblastic Leukemia | Central Nervous System Leukemia | Testicular Leukemia | B Acute Lymphoblastic Leukemia, BCR-ABL1-LikeUnited States, Canada, Puerto Rico, Australia, New Zealand, Switzerland, Ireland
-
Novartis PharmaceuticalsCompletedHypereosinophilic Syndrome | Chronic Myelogenous Leukemia | Systemic Mastocytosis | Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)United States, Poland, Italy, Belgium, Canada, France, Australia, Netherlands, Sweden, Switzerland, United Kingdom, Spain, Korea, Republic of, Austria, Germany, Denmark, Finland, Singapore, Taiwan, Hong Kong, New Zealand, Norway
-
National Cancer Institute (NCI)Children's Oncology GroupActive, not recruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Rhabdoid Tumor | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Ann Arbor Stage III Hodgkin Lymphoma | Ann Arbor Stage IV Hodgkin Lymphoma | Recurrent Ependymoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent... and other conditionsUnited States, Puerto Rico
-
National Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States, Canada, Australia, New Zealand, Puerto Rico
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaAustria, Italy, Spain, United Kingdom, Belgium, Taiwan, France, Korea, Republic of, Hungary, United States, Ukraine, Canada, Australia, Germany, Israel, Czechia, Russian Federation, Slovakia, Poland, Bulgaria, New Zealand, Sweden, C... and more
-
Hoffmann-La RocheActive, not recruitingMelanoma | Renal Cell Carcinoma | Adult Solid Tumor | Breast Cancer | Head and Neck Neoplasms | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Neuroendocrine Tumors | Lymphoma, Large-Cell, Anaplastic | Cholangiocarcinoma | Papillary Thyroid Cancer | Sarcomas | Salivary Gland Cancers and other conditionsUnited States, China, Korea, Republic of, Australia, Taiwan, France, Spain, United Kingdom, Hong Kong, Belgium, Italy, Germany, Japan, Singapore, Netherlands, Poland
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingSoft Tissue Sarcoma | Lymphoma | Acute Myeloid Leukemia | Leukemia | Osteosarcoma | Acute Lymphoblastic Leukemia | Ewing Sarcoma | Rhabdoid Tumor | Neuroblastoma | Retinoblastoma | Rhabdomyosarcoma | Malignant Neoplasm | Germ Cell Tumor | Central Nervous System NeoplasmUnited States, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedB-cell Childhood Acute Lymphoblastic Leukemia | L1 Childhood Acute Lymphoblastic Leukemia | L2 Childhood Acute Lymphoblastic Leukemia | Intermediate Risk Recurrent Childhood Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI); MedStar Georgetown University HospitalActive, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Malignant Neoplasm | Bacterial Infection | Myeloid Neoplasm | Benign Neoplasm | Methicillin-Resistant Staphylococcus Aureus InfectionUnited States, Canada, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingLeukemia | Solid Tumor | Hematopoietic Cell Transplantation RecipientUnited States, Puerto Rico
-
National Cancer Institute (NCI)Active, not recruitingSoft Tissue Sarcoma | Osteosarcoma | Ewing Sarcoma | Malignant Glioma | Ependymoma | Rhabdoid Tumor | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Rhabdomyosarcoma | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Refractory Neuroblastoma | Refractory Non-Hodgkin Lymphoma and other conditionsUnited States, Puerto Rico
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed